Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by TripleEmon Mar 26, 2018 10:32pm
69 Views
Post# 27785611

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Capital raise by Tetra is going to launch this company!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Capital raise by Tetra is going to launch this company!Management Statement 
“This is an important transaction for Tetra and our shareholders. Not only have we monetized an asset that brings immediate cash into the business but we also have an equity stake in North Bud that we intend to distribute to our shareholders. 
Read more at https://www.stockhouse.com/news/press-releases/2018/02/22/tetra-bio-pharma-announces-the-completion-of-growpros-transaction#gfDdC8BlIVOykrXP.99

gkmackdadzzz1 wrote: "With respect to the statements relating the Corporation's revenue targets in respect of Rx Princeps, the announced expected target sales of $1,500,000 for fiscal year 2018 is based on a bottom-up forecast model using a progressive enrolment of patients through Aphria Inc. ("Aphria"),"

so the company fronted (yes, over 3 years) 12M to MEMBER'S OF TETRAS TEAM for a product that COULD potentially bring in 1.5M if they capture all of this market share?
 
hmmmm......

looking out for yourself first and shareholders last.  go ahead and one star my posts.....put there's something not transparent about this transaction, especially after reading all the additional caveats. 




LeafRider wrote: So what makes you an expert in knowing what fair compensation is for creating a Bio-pharma company and developing the science behind the medicine. Are you some kind of expert on the topic. Fact is, you know absolutely nothing related to the efforts of drug development. The fact that you say "this company issues too many shares", doesn't make it true.

Anyone reading this bull$hit should understand that management teams get compensated all the time. If you want go digging into the other bio-pharma companies and you'll see similar strategies exist for co-founders of these companies. People who put up big capital at the onset of a project and make it happen, get paid. Very simple!

Plus Gkmack knows absolutely squat about the capital, time, effort, and costs that were associated to the effort at the hands of Chamberland and Rancourt. These two are the true creators and founders of Tetra  Bio Pharma, the others simply left for Northbud or "greener" pastures to start a growop. The Growpros license will eventually see Health Canada approval, and when it does we'll own 41% of Northbud.

This moron gkmack would also like us to believe that commencing a phase 3 clinical trial which is approved by Health Canada and also the FDA, which is near reaching DIN#'s approval once a successful phase 3 clinical is complete; is something that happens all the time, and isn't worthy of discussion. So we aren't allowed to talk about the positive developments with Tetra, because Gkmack wants to talk about how many shares are being handed out. Okay let the muzzle order stand - Gkmackloser, Aviator, and WigWag can stand around the circle jerk and pleasure each other!

gkmackdadzzz1 wrote: nothing matters on the board. cause rather than acknowledging that this company issues way too many options and warrants employees, that would rather continue to talk about a "DIN" - cause they believe there is not straight competion for this formulations by companies that already generating revenue and already have named distribution channels (not like TBP announcing it twice and not disclosing the partner).  or they could be like you and PM what mistakes means in TBP's sedar filings.



stocktickler87 wrote: If people try to convince the board of credibility but nobody cares, did it even happen? 

 

 




<< Previous
Bullboard Posts
Next >>